Nishimori H - Search Results

1

Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study.

Yokota T, Ogawa T, Takahashi S, Okami K, Fujii T, Tanaka K, Iwae S, Ota I, Ueda T, Monden N, Matsuura K, Kojima H, Ueda S, Sasaki K, Fujimoto Y, Hasegawa Y, Beppu T, Nishimori H, Hirano S, Naka Y, Matsushima Y, Fujii M, Tahara M. Yokota T, et al. Among authors: nishimori h. BMC Cancer. 2017 May 5;17(1):314. doi: 10.1186/s12885-017-3295-4. BMC Cancer. 2017. PMID: 28476132 Free PMC article. Clinical Trial.

2

Donor cell-derived hematological malignancy: a survey by the Japan Society for Hematopoietic Cell Transplantation.

Kato M, Yamashita T, Suzuki R, Matsumoto K, Nishimori H, Takahashi S, Iwato K, Nakaseko C, Kondo T, Imada K, Kimura F, Ichinohe T, Hashii Y, Kato K, Atsuta Y, Taniguchi S, Fukuda T. Kato M, et al. Among authors: nishimori h. Leukemia. 2016 Aug;30(8):1742-5. doi: 10.1038/leu.2016.23. Epub 2016 Feb 12. Leukemia. 2016. PMID: 26867671 No abstract available.

3

Reduced expression and rare genomic alteration of nm23-H1 in human hepatocellular carcinoma and hepatoma cell lines.

Fujimoto Y, Ohtake T, Nishimori H, Ikuta K, Ohhira M, Ono M, Kohgo Y. Fujimoto Y, et al. Among authors: nishimori h. J Gastroenterol. 1998 Jun;33(3):368-75. doi: 10.1007/s005350050098. J Gastroenterol. 1998. PMID: 9658316

4

Silica nanoparticles as hepatotoxicants.

Nishimori H, Kondoh M, Isoda K, Tsunoda S, Tsutsumi Y, Yagi K. Nishimori H, et al. Eur J Pharm Biopharm. 2009 Aug;72(3):496-501. doi: 10.1016/j.ejpb.2009.02.005. Epub 2009 Feb 14. Eur J Pharm Biopharm. 2009. PMID: 19232391

5

Histological analysis of 70-nm silica particles-induced chronic toxicity in mice.

Nishimori H, Kondoh M, Isoda K, Tsunoda S, Tsutsumi Y, Yagi K. Nishimori H, et al. Eur J Pharm Biopharm. 2009 Aug;72(3):626-9. doi: 10.1016/j.ejpb.2009.03.007. Epub 2009 Mar 31. Eur J Pharm Biopharm. 2009. PMID: 19341796

6

Hepatocellular carcinoma in 13 patients with hepatitis C virus-associated chronic hepatitis.

Watanabe A, Nishimori H, Tsukishiro T, Okada K, Shimizu Y, Nambu S, Miyabayashi C, Takahara T, Higuchi K. Watanabe A, et al. Among authors: nishimori h. J Gastroenterol Hepatol. 1994 Jan-Feb;9(1):30-4. doi: 10.1111/j.1440-1746.1994.tb01212.x. J Gastroenterol Hepatol. 1994. PMID: 8155863

7

Analyses of proliferating cell nuclear antigen-positive cells in hepatocellular carcinoma: comparisons with clinical findings.

Nishimori H, Tsukishiro T, Nambu S, Okada K, Shimizu Y, Miyabayashi C, Higuchi K, Watanabe A. Nishimori H, et al. J Gastroenterol Hepatol. 1994 Sep-Oct;9(5):425-32. doi: 10.1111/j.1440-1746.1994.tb01268.x. J Gastroenterol Hepatol. 1994. PMID: 7827290

8

Etiology and prognosis of cryptogenic liver cirrhosis: possible contribution of hepatitis B virus.

Watanabe A, Aiba N, Harada R, Miyabayashi C, Entani A, Wakabayashi H, Nishimori H, Kuwabara Y. Watanabe A, et al. Among authors: nishimori h. J Med. 1997;28(1-2):31-44. J Med. 1997. PMID: 9249608

9

Influence of 70 nm silica particles in mice with cisplatin or paraquat-induced toxicity.

Nishimori H, Kondoh M, Isoda K, Tsunoda S, Tsutsumi Y, Yagi K. Nishimori H, et al. Pharmazie. 2009 Jun;64(6):395-7. Pharmazie. 2009. PMID: 19618677

10

Evaluation of promoter strength in mouse and rat primary hepatocytes using adenovirus vectors.

Arita E, Kondoh M, Isoda K, Nishimori H, Yoshida T, Mizuguchi H, Yagi K. Arita E, et al. Among authors: nishimori h. Eur J Pharm Biopharm. 2008 Sep;70(1):1-6. doi: 10.1016/j.ejpb.2008.03.013. Epub 2008 Mar 29. Eur J Pharm Biopharm. 2008. PMID: 18468873

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

270 results

Search Page

Filters